IFP Advisors’s BioAtla BCAB Stock Holding History

IFP Advisors’s Portfolio BCAB Stock Details BCAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4	Closed	-$309	–	3075
2023 Q3	$309	Hold	4	–	–	﹤0.01%	3151
2023 Q2	$546	Hold	4	–	–	﹤0.01%	3185
2023 Q1	$5.65K	Hold	4	–	–	﹤0.01%	2515
2022 Q4	$6K	Hold	4	–	–	﹤0.01%	3664
2022 Q3	$6K	Hold	4	–	–	﹤0.01%	3912
2022 Q2	$6K	Hold	4	–	–	﹤0.01%	3658
2022 Q1	$6K	Buy	+4	New	+$1.67K	﹤0.01%	3658

Other funds holding BCAB

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IFP Advisors's BCAB Position: Q4 2023 in Review

IFP Advisors sold out of BioAtla (BCAB) in Q4 2023, closing a stake of 4 shares — an estimated $309 sold.

IFP Advisors first reported a position in BCAB in Q1 2022 and held it in 7 quarters. The position peaked at $6K in Q4 2022. 79 funds tracked by Wall St. Rank hold BCAB as of Q4 2023.

IFP Advisors reported no remaining BioAtla position as of Q4 2023 after selling out during the quarter.
IFP Advisors sold 4 BioAtla shares in Q4 2023, an estimated $309.
IFP Advisors first reported a position in BioAtla in Q1 2022 and held it in 7 quarters.
IFP Advisors's BioAtla position peaked at $6K in Q4 2022.
79 funds tracked by Wall St. Rank held BioAtla as of Q4 2023.

Based on IFP Advisors's 13F filing for Q4 2023, filed 9 Jan 2024.